1Y Close · As of Aug 26, 2026
IMBiologics operates in the Professional Services sector.
Legal name: IMBiologics Corp.
In fiscal year 2025, IMBiologics (493280) reported revenue of 11.6 billion KRW, down 57.9% from 27.6 billion KRW a year earlier.
Operating profit was 298 million KRW and net income was 877 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 233.8 billion KRW, with a P/B of 3.18.
These figures can be verified in the DART filing (receipt no. 20260325001160).
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-12 | Semi-Annual Report (2026.06) |